Nyxoah SA (NYXH) Financials

NYXH Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 142.5 million 27.6 million
2023-06-30 154.8 million 29.2 million
2023-03-31 164.5 million 28.3 million
2022-12-31 156.8 million 27.6 million

NYXH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -15.0 million 557905
2023-06-30 -15.6 million 813326
2023-03-31 -15.0 million 1.1 million
2022-12-31 -15.5 million 603122

NYXH Net Income

No data available :(

NYXH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 76.7 million - 4.0 million
2023-06-30 91.9 million - 4.1 million
2023-03-31 104.7 million - 4.2 million
2022-12-31 101.8 million - 3.5 million

NYXH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 30.3 million
2023-06-30 31.1 million
2023-03-31 28.2 million
2022-12-31 27.7 million

NYXH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.8 million 7.0 million 5.1 million -
2023-06-30 2.8 million 7.2 million 6.5 million -
2023-03-31 3.4 million 6.7 million 5.8 million -
2022-12-31 4.4 million 4.9 million 5.4 million 316585

NYXH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.0 million 355704
2023-06-30 1.2 million 455593
2023-03-31 480693 190751
2022-12-31 1.4 million 499025

NYXH

Price: $10.62

52 week price:
4.00
20.00

Earnings Per Share: -1.67 USD

P/E Ratio: -6.97

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 11600

Market Capitalization: 367.2 million

Links: